𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drugging the Bad “AKT-TOR” to Overcome TKI-Resistant Lung Cancer

✍ Scribed by Jeffrey Settleman; Jonathan M. Kurie

Book ID
113523758
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
78 KB
Volume
12
Category
Article
ISSN
1535-6108

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting BCL-2 family proteins to overc
Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer
✍ Emmanuelle Wesarg; Sandra Hoffarth; Rainer Wiewrodt; Monika Kröll; Stefan Bieste 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 422 KB

## Abstract Cytotoxic chemotherapies are standard of care for patients suffering from advanced non‐small cell lung cancer (NSCLC). However, objective responses are only achieved in 20% of cases and long‐term survival is rarely observed. Clinically applied anticancer drugs exert at least some of the